rs786200956
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_006766.5(KAT6A):c.4292dupT(p.Leu1431PhefsTer8) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006766.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.4292dupT variant, located in coding exon 16 of the KAT6A gene, results from a duplication of T at nucleotide position 4292, causing a translational frameshift with a predicted alternate stop codon. This alteration was detected as a de novo occurrence in an individual with global developmental delay, speech delay, neonatal hypotonia, crainofacial features, and eye and feeding problems (Tham E et al. Am. J. Hum. Genet., 2015 Mar;96:507-13). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This nucleotide position is highly conserved in available vertebrate species. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
not provided Uncertain:1
The KAT6A gene is a candidate gene. This variant requires further evaluation in a research setting. To date, no mutations in the KAT6A gene have been reported in association with a specific human disease to our knowledge. However, multiple patients presenting with global developmental delay, dysmorphic facial features, hypotonia, and cardiac anomalies were found to carry a de novo variant in the KAT6A gene at GeneDx. While the function of KAT6A has not been completely defined, studies in mice suggest that KAT6A may act as a chromatin modifier by interacting with the TBX1 gene. Mutations in the TBX1 gene as well as contiguous gene deletions including the TBX1 gene within cytogenetic band 22q11 cause Velocardiofacial/DiGeorge syndrome. KAT6A-null mice have features that mirror the 22q11 deletion syndrome, suggesting KAT6A is involved in cardiac, pharyngeal and facial development (Voss et al., 2012).;c.4292dupT: p.Leu1431PhefsX8 (L1431FfsX8) in exon 18 in the KAT6A gene (NM_001099412.1). The normal sequence with the base that is duplicated in braces is: TCTT{T}GACT. The apparently c.4292dupT variant in the KAT6A gene has not been reported previously, to our knowledge. This variant causes a frameshift starting with codon Leucine 1431, changes this amino acid to a Phenylalanine residue and creates a premature Stop codon at position 8 of the new reading frame, denoted p.Leu1431PhefsX8. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant has been seen de novo. The variant is found in KAT6A panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at